top of page

Jisu Hong

홍지수_edited_edited.jpg

M.S./PH.D. INTEGRATED COURSE from Sep 2021

Department of Biomedical Sciences, SNUCM​

B.S. Department of chemistry, Chungnam National University,

Republic of Korea​

Seoul National University Graduate School of Medicine, 26th undergraduate researcher

​Research interests

Development of therapeutic antibodies, Therapeutic antibody engineering,  CAR cell therapy​

Awards

Selected as an Excellent Graduate Student in March 2022 under the 4th stage of the BK21 program

 

e-mail: redj0106@snu.ac.kr

Publications

 

4. Hae Nim Lee, Soojin Lee, Jisu Hong, Hyejin Yoo, Jiyun Jeong, Yong-Woo Kim, Hyun Mu Shin, Mihue Jang*, Chang-Han Lee*, Hang-Rae Kim* and Jihye Seong*

# Co-first author, *Co-corresponding author

​​​

Novel FRET-Based Immunological Synapse Biosensor for the Prediction of CAR-T Cell Function

 

Small Methods (IF: 10.7), Sep 2024

​​

3. Chang Kyung Kang#, Hyun Mu Shin#, Pyoeng Gyun Choe, Jiyoung Park,  Jisu Hong, Jung Seon Seo, Yung Hie Lee, Euijin Chang, Nam Joong Kim, Minji Kim, Yong-Woo Kim, Hang-Rae Kim, Chang-Han Lee*, Jun-Young Seo*, Wan Beom Park*, Myoung-don Oh

# Co-first author, *Co-corresponding author

​​

Broad humoral and cellular immunity elicited by one dose mRNA vaccination 18 months after SARS-CoV-2 infection

BMC Medicine (IF: 11.150), 20, 181 (2022)

2. Pyoeng Gyun Choe#, Jisu Hong#, Jiyoung Park, Euijin Chang, Chang Kyung Kang, Nam Joong Kim, Chang-Han Lee*, Wan Beom Park*, and Myoung-don Oh

# Co-first author, *Co-corresponding author

​​

Persistent Antibody Responses up to 18 Months after Mild SARS-CoV-2 Infection

​​

Journal of Infectious Diseases (IF: 7.759), 17 March 2022

1. Chang Kyung Kang#, Minji Kim#, Jisu Hong#, Gwanghun Kim, Soojin Lee, Pyoeng Gyun Choe, Nam Joong Kim, Ik Soo Kim, Jun-Young Seo, Daesub Song, Dong-Sup Lee,  Hyun Mu Shin, Chang-Han Lee*, Wan Beom Park*, Hang-Rae Kim* and Myoung-don Oh

# Co-first author, *Co-corresponding author

​​

Distinctive immune response after one-year post COVID-19 according to the severity

​​

Frontiers in Immunology (IF:8.786), 21 March 2022, vol 13, 830433

bottom of page